{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-035123","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.716860+00:00","generated_at":"2026-06-13T06:18:23.054114+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ADMA Biologics receives FDA approval for ninth plasma collection center in Dallas, GA","bullets":["FDA approved Dallas, GA facility's BLA; center began plasma collection in Q3 2022.","Facility now licensed to collect and ship source plasma interstate for manufacturing.","Company on track to have all 10 centers FDA-licensed by year-end 2023.","Supports plasma self-sufficiency, revenue growth, and profitability outlook.","Facility features Haemonetics NexSys Persona system; expects staff of 50 at capacity."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-035123","json":"https://secwatch.observer/filing/0001140361-23-035123.json","markdown":"https://secwatch.observer/filing/0001140361-23-035123.md","text":"https://secwatch.observer/filing/0001140361-23-035123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123035123/0001140361-23-035123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123035123/brhc20056054_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:18:23.054114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}